Vital Farms (NASDAQ:VITL – Get Free Report) announced its earnings results on Thursday. The company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.03), FiscalAI reports. Vital Farms had a return on equity of 20.19% and a net margin of 8.50%.The company had revenue of $213.55 million during the quarter, compared to analysts’ expectations of $212.83 million. During the same quarter last year, the firm posted $0.23 EPS. Vital Farms’s revenue for the quarter was up 28.6% compared to the same quarter last year.
Here are the key takeaways from Vital Farms’ conference call:
- Company delivered record 2025 results with net revenue up >25% to $759.4 million and Adjusted EBITDA surpassing $100 million for the first time at $114 million.
- Operational progress — rebuilt egg inventory, brought a third ECS production line online, completed ERP implementation with no unplanned shipment interruptions, and expanded the farm network to >600 farms — creating unconstrained supply to support scale toward the $2 billion by 2030 target.
- 2026 guidance: net revenue of $900–$920 million (>20% growth) and Adjusted EBITDA of $105–$115 million (midpoint ~12% margin), with CapEx of $140–$150 million; management says margins compress as it reinvests prior price increases into promotions to drive household penetration.
- Leadership change: founder Matt O’Hayer retired as executive chair and board member while remaining the largest shareholder and an advisor, and Russell Diez-Canseco was named Executive Chairperson and CEO — continuity emphasized but governance shift is notable.
Vital Farms Stock Down 10.8%
Shares of VITL stock traded down $2.68 on Thursday, hitting $22.11. The stock had a trading volume of 12,828,552 shares, compared to its average volume of 1,868,367. The company has a quick ratio of 2.15, a current ratio of 2.65 and a debt-to-equity ratio of 0.02. Vital Farms has a one year low of $19.80 and a one year high of $53.13. The business has a 50 day moving average price of $29.04 and a 200 day moving average price of $36.40. The company has a market cap of $990.09 million, a PE ratio of 16.75 and a beta of 1.10.
Insider Activity
Hedge Funds Weigh In On Vital Farms
A number of large investors have recently added to or reduced their stakes in the company. Royal Bank of Canada increased its position in Vital Farms by 89.2% during the 1st quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock valued at $591,000 after buying an additional 9,136 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Vital Farms by 5.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock valued at $611,000 after acquiring an additional 1,108 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Vital Farms by 3.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock worth $12,658,000 after purchasing an additional 13,397 shares during the last quarter. Woodline Partners LP purchased a new stake in shares of Vital Farms during the first quarter worth approximately $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Vital Farms by 1.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock valued at $2,739,000 after buying an additional 1,198 shares during the last quarter. 98.59% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
VITL has been the topic of a number of recent analyst reports. DA Davidson set a $47.00 price objective on shares of Vital Farms and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Vital Farms in a report on Monday, December 29th. Benchmark cut Vital Farms from a “buy” rating to a “hold” rating in a report on Thursday. Jefferies Financial Group reiterated a “buy” rating and issued a $52.00 target price on shares of Vital Farms in a research note on Wednesday, December 17th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $45.00 target price on shares of Vital Farms in a research report on Friday, January 30th. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $49.91.
Check Out Our Latest Research Report on VITL
About Vital Farms
Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.
Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.
Featured Articles
- Five stocks we like better than Vital Farms
- Read this or regret it forever
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Receive News & Ratings for Vital Farms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Farms and related companies with MarketBeat.com's FREE daily email newsletter.
